CHAMPIONS ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-04-30 was 71.60K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-01-31 was 6.67K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-10-31 was 105.14K shares, a 8.22% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-07-31 was 0.00 shares, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 109.66K shares, a 40.21% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 183.40K shares, a 17.98% increase from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 155.45K shares, a 329.31% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 36.21K shares, a 66.59% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-04-30 | 109.66K shares 10-K · filed 2026-07-27 | |
| 2025-04-30 | 71.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | 183.40K shares 10-K · filed 2025-07-23 |
| 2025-01-31 | 6.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | 111.80K shares derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-10-31 | 105.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | 105.14K shares derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-07-31 | 0.00 shares 10-Q · filed 2024-09-13 | 114.55K shares derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | 155.45K shares 10-K · filed 2025-07-23 |
| 2024-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | 155.45K shares derived: sum of 4 quarters · filed 2024-07-19 |
| 2023-10-31 | 114.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13 | 155.45K shares derived: sum of 4 quarters · filed 2024-07-19 |
| 2023-07-31 | 40.90K shares 10-Q · filed 2023-09-13 | |
| 2023-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | 36.21K shares 10-K · filed 2024-07-19 |
| 2023-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | |
| 2022-04-30 | 4.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | 108.38K shares 10-K · filed 2023-07-24 |
| 2022-01-31 | 21.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | 127.77K shares derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-10-31 | 81.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | 127.60K shares derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-07-31 | 1.00K shares 10-Q · filed 2021-09-13 | 687.18K shares derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-04-30 | 23.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | 687.34K shares 10-K · filed 2022-07-22 |
| 2021-01-31 | 21.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | 708.20K shares derived: sum of 4 quarters · filed 2021-07-26 |
| 2020-10-31 | 640.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | 889.69K shares derived: sum of 4 quarters · filed 2021-07-26 |
| 2020-07-31 | 1.16K shares 10-Q · filed 2020-09-14 | 249.66K shares derived: sum of 4 quarters · filed 2021-07-26 |
| 2020-04-30 | 44.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | 248.50K shares 10-K · filed 2021-07-26 |
| 2020-01-31 | 203.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | 209.88K shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-10-31 | 625.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | -16.92K shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-07-31 | 0.00 shares 10-Q · filed 2019-09-16 | 343.38K shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-04-30 | 6.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | 363.38K shares 10-K · filed 2020-07-28 |
| 2019-01-31 | -23.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | 357.24K shares derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-10-31 | 360.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | 393.43K shares derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-07-31 | 20.00K shares 10-Q · filed 2018-09-14 | 32.50K shares derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | 12.50K shares 10-K · filed 2019-07-29 |
| 2018-01-31 | 12.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | 12.50K shares derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | 0.00 shares derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-07-31 | 0.00 shares 10-Q · filed 2017-09-14 | 0.00 shares derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | 0.00 shares 10-K · filed 2018-07-30 |
| 2017-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | 0.00 shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2016-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | 0.00 shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2016-07-31 | 0.00 shares 10-Q · filed 2016-09-14 | 0.00 shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2016-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | 0.00 shares 10-K · filed 2017-07-28 |
| 2016-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -3.44K shares derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -3.44K shares derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-07-31 | 0.00 shares 10-Q · filed 2015-09-11 | |
| 2015-04-30 | -3.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | 313.00 shares 10-K · filed 2016-07-29 |
| 2015-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | |
| 2014-04-30 | 18.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | 33.75K shares 10-K · filed 2015-07-29 |
| 2014-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | |
| 2013-04-30 | 0.00 shares 10-K · filed 2014-07-28 | |
| 2012-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | |
| 2012-07-31 | 0.00 shares 10-Q · filed 2012-09-12 | |
| 2012-04-30 | 50.00K shares 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |